Hyperuricemia(HUA)not only impairs transplanted kidney function and contributes to uric acid nephropathy but also elevates the risk of gouty arthritis and cardiovascular disease,making it a significant risk factor for long-term survival of kidney transplant(KT)recipients.To standardize the diagnosis and treatment of HUA in KT recipients in China,Branch of Organ Transplantation,Chinese Medical Association has convened the relevant experts in KT,rheumatology and endocrinology to formulate the 2023 Edition Chinese Guidelines for Diagnosing and Treating Hyperuricemia in Kidney Transplant Recipients.These guidelines provide detailed evidence-based recommendations for 10 key clinical issues of managing HUA and gout in KT recipients.
万方数据
